Recent researches have indicated a significantly lower expression of SLC7A11 in tumor-infiltrating CD8+T cells compared to tumor cells, suggesting a disadvantage for CD8+T cells in competing for cystine. This evidence concerns the gene SLC7A11 and neoplasm.